サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1342920

遺伝子パネルの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Gene Panel Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 221 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
遺伝子パネルの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 221 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子パネル市場の世界需要は、調査期間2023～2030年のCAGR20.2%で、2022年の32億9,000万米ドルから2030年には143億2,000万米ドル近くの市場規模に達すると推定されます。

遺伝子パネル検査は、患者が様々な疾患によって引き起こされる可能性のある症状を示す場合や、複数の遺伝子の変異が疑われる疾患の原因となる場合に、診断を絞り込むために使用される診断検査です。遺伝子パネル検査は、多数の遺伝子を調べることができるため、がんの情報を提供し、がんの転移を防ぐための確実な診断に役立ちます。遺伝子パネルは、がんリスク評価、症候群特異的診断、疾患浸透、その他多くの用途など、診断や治療に使用されています。

市場力学：

市場成長の重要な要因は、慢性疾患の罹患率と有病率の上昇です。さらに、診断サービスにおける技術進歩の増加とヘルスケア技術の近代化が市場の成長を促進しています。また、進行中の研究開発が遺伝子パネル市場を牽引しています。さらに、男性および女性におけるがん患者数の増加と、がんと闘うための遺伝子パネル市場の利点が、市場成長の原動力となっています。しかし、高価格と遺伝子報告書の信憑性に対する個人間の深刻な疑念が、遺伝子パネル市場成長の主な抑制要因となっています。加えて、遺伝子検査の潜在的な利点に関する意識の高まり、高度医療検査に対する需要の増加、標的アプローチと個別化医療に対する需要の高まりは、世界の遺伝子パネル市場の成長の主な促進要因です。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、競合の魅力を世界レベルで評価するのに役立ちます。さらに、これらのツールは遺伝子パネルの世界市場における各セグメントを包括的に評価することもできます。遺伝子パネル産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおける遺伝子パネル市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 遺伝子パネル- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 遺伝子パネルの世界市場分析：製品・サービス別

  • 製品・サービス別概要
  • 実績データと予測データ
  • 製品・サービス別分析
  • 検査キット
  • 検査サービス

第7章 遺伝子パネルの世界市場分析：技術別

  • 技術別概要
  • 実績データと予測データ
  • 技術別分析
  • アンプリコンベースのアプローチ
  • ハイブリダイゼーションベースのアプローチ

第8章 遺伝子パネルの世界市場分析：設計別

  • 設計別概要
  • 実績データと予測データ
  • 設計別分析
  • 設計済み遺伝子パネル
  • カスタマイズ遺伝子パネル

第9章 遺伝子パネルの世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • がんリスク評価（症候群特異的、高発現率、高・中発現率、包括的がんリスク、先天性疾患診断）
  • 薬理遺伝学
  • その他の用途

第10章 遺伝子パネルの世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 調査・学術機関
  • 病院および診断研究所
  • 製薬・バイオテクノロジー企業

第11章 遺伝子パネルの世界市場分析：地域別

  • 上位企業シェア分析
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第12章 遺伝子パネル企業の競合情勢

  • 遺伝子パネル市場競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第13章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Illumina Inc.（米国）
  • BGI（中国）
  • Agilent Technologies（米国）
  • Eurofins Scientific（米国）
  • QIAGEN（ドイツ）
  • GENEWIZ Inc.（米国）
  • Novogene Corporation（中国）
  • Personalis（米国）
  • Thermo Fisher Scientific（米国）
  • F. Hoffmann-La Roche AG（スイス）
  • Integrated DNA Technologies（IDT）（米国）
  • GATC Biotech AG（GATC Biotech）（ドイツ）
  • ArcherDx（米国）
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Service (USD MN)
  • Test Kits Market Sales by Geography (USD MN)
  • Testing Services Market Sales by Geography (USD MN)
  • Analysis Market by Technique (USD MN)
  • Amplicon-based Approach Market Sales by Geography (USD MN)
  • Hybridization-based Approach Market Sales by Geography (USD MN)
  • Analysis by Design (USD MN)
  • Predesigned Gene Panel Market Sales by Geography (USD MN)
  • Customized Gene Panel Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Cancer Risk Assessment (Syndrome-specific, High-penetrance, High And Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases) Market Sales by Geography (USD MN)
  • Pharmacogenetics Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Research And Academic Institutes Market Sales by Geography (USD MN)
  • Hospital And Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Global Gene Panel Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Gene Panel Report
  • Market Research Process
  • Market Research Methodology
  • Global Gene Panel Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Technique
  • Market Attractiveness Analysis by Design
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Test Kits Market Sales by Geography (USD MN)
  • Testing Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Technique (USD MN)
  • Amplicon-based Approach Market Sales by Geography (USD MN)
  • Hybridization-based Approach Market Sales by Geography (USD MN)
  • Global Market Analysis by Design (USD MN)
  • Predesigned Gene Panel Market Sales by Geography (USD MN)
  • Customized Gene Panel Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Cancer Risk Assessment (Syndrome-specific, High-penetrance, High And Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases) Market Sales by Geography (USD MN)
  • Pharmacogenetics Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Research And Academic Institutes Market Sales by Geography (USD MN)
  • Hospital And Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219275

The global demand for Gene Panel Market is presumed to reach the market size of nearly USD 14.32 BN by 2030 from USD 3.29 BN in 2022 with a CAGR of 20.2% under the study period 2023 - 2030.

Gene panel is a diagnostic test used to narrow down a diagnosis when the patient shows symptoms that can be caused by a variety of conditions or when variants in multiple genes can cause the suspected condition. Gene panel tests can examine large numbers of genes which helps provide cancer information and provides a secure diagnosis to prevent cancer spread. Gene panel are used in diagnostics and treatments such as cancer risk assessment, syndrome-specific diagnostics, disease penetration, and many other applications.

MARKET DYNAMICS:

The significant factor attributing to the market's growth is the rising incidence and prevalence of chronic diseases. Moreover, increasing technological advancement in diagnostics services and modernization in healthcare techniques are driving the market's growth. Also, the growing ongoing research and development drive the gene panel market. Furthermore, the increasing number of cancer cases in males and females and the benefits of the gene panel market to fight cancer drive market growth. However, high prices and serious doubts among individuals about the authenticity of genetic reports are the major restraints of the gene panel market growth. In addition, growing awareness about the potential benefits of genetic testing, increasing demand for advanced medical testing, and rising demand for targeted approaches and personalized medicine are the primary drivers of the growth of the global gene panel market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gene panel. The growth and trends of gene panel industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the gene panel market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Test Kits
  • Testing Services

By Technique

  • Amplicon-Based Approach
  • Hybridization-Based Approach

By Design

  • Predesigned Gene Panel
  • Customized Gene Panel

By Application

  • Cancer Risk Assessment (Syndrome-Specific, High-Penetrance, High And Moderate-Penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases)
  • Pharmacogenetics
  • Other Applications

By End User

  • Research And Academic Institutes
  • Hospital And Diagnostic Laboratories
  • Pharmaceutical And Biotechnology Companies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Gene Panel market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gene panel market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . GENE PANEL - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Technique
    • 3.7.3 Market Attractiveness Analysis By Design
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL GENE PANEL MARKET ANALYSIS BY PRODUCT & SERVICE

  • 6.1 Overview by Product & Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product & Service
  • 6.4 Test Kits Historic and Forecast Sales by Regions
  • 6.5 Testing Services Historic and Forecast Sales by Regions

7 . GLOBAL GENE PANEL MARKET ANALYSIS BY TECHNIQUE

  • 7.1 Overview by Technique
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Technique
  • 7.4 Amplicon-based Approach Historic and Forecast Sales by Regions
  • 7.5 Hybridization-based Approach Historic and Forecast Sales by Regions

8 . GLOBAL GENE PANEL MARKET ANALYSIS BY DESIGN

  • 8.1 Overview by Design
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Design
  • 8.4 Predesigned Gene Panel Historic and Forecast Sales by Regions
  • 8.5 Customized Gene Panel Historic and Forecast Sales by Regions

9 . GLOBAL GENE PANEL MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Cancer Risk Assessment (Syndrome-specific, High-penetrance, High And Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases) Historic and Forecast Sales by Regions
  • 9.5 Pharmacogenetics Historic and Forecast Sales by Regions
  • 9.6 Other Applications Historic and Forecast Sales by Regions

10 . GLOBAL GENE PANEL MARKET ANALYSIS BY END USER

  • 10.1 Overview by End User
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End User
  • 10.4 Research And Academic Institutes Historic and Forecast Sales by Regions
  • 10.5 Hospital And Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 10.6 Pharmaceutical And Biotechnology Companies Historic and Forecast Sales by Regions

11 . GLOBAL GENE PANEL MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE GENE PANEL COMPANIES

  • 12.1. Gene Panel Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF GENE PANEL INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Illumina Inc. (US)
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. BGI (China)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Agilent Technologies (US)
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Eurofins Scientific (US)
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. QIAGEN (Germany)
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. GENEWIZ Inc. (US)
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Novogene Corporation (China)
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Personalis (US)
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Thermo Fisher Scientific (US)
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. F. Hoffmann-La Roche AG (SwitzerlAnd)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Integrated DNA Technologies (IDT) (US)
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. GATC Biotech AG (GATC Biotech) (Germany)
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. ArcherDx (US)
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies